Psyence Biomedical Ltd. Common Shares

Psyence Biomedical Ltd. (PBM) is an innovative biotechnology company focused on harnessing the therapeutic potential of psychedelic compounds to address mental health and wellness challenges. The company employs a vertically integrated model, encompassing the cultivation, formulation, and clinical research of psilocybin and other psychedelics, which allows for thorough control over its product development processes. With a robust intellectual property portfolio and a progressive clinical pipeline, Psyence is strategically positioned to leverage the increasing acceptance of psychedelic therapies in the healthcare marketplace, aiming to deliver effective solutions that meet the urgent needs of patients.

Sector

Healthcare

Industry

Biotechnology

Country

USA

Fiscal year end

March

Website

psyencebiomed.com